Prot #MNA-3521-012: An Open Label Phase 1A/B Study Of Mtl-Cebpa In Combination With A Pd-1 Inhibitor (Pembrolizumab) In Adult Patients With Advanced Solid Tumours (TIMEPOINT)

Project: Research project

Project Details

StatusActive
Effective start/end date11/29/2111/29/24

Funding

  • Ergomed Clinical Research Inc. ((OE) Prot #MNA-3521-012 // (OE) Prot #MNA-3521-012)
  • MiNA Alpha Limited ((OE) Prot #MNA-3521-012 // (OE) Prot #MNA-3521-012)